<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2170">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04336345</url>
  </required_header>
  <id_info>
    <org_study_id>3336</org_study_id>
    <nct_id>NCT04336345</nct_id>
  </id_info>
  <brief_title>Outcomes of Patients With COVID-19 in the Intensive Care Unit</brief_title>
  <acronym>MexCOVID-19</acronym>
  <official_title>Outcomes of Patients With COVID-19 in the Intensive Care Unit: A National Observational Study (Mexico COVID-19 ICU Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the clinical characteristics and outcomes of
      critically ill patients with COVID-19 admitted to the intensive care unit.

      A Multicenter Observational Study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As of 23 March 2020, a cumulative total of 332,930 confirmed cases of coronavirus disease
      2019 (COVID-19) were reported in 189 countries and territories worldwide. As of this time,
      there had been 367 total confirmed cases of COVID-19, including four deaths in Mexico. The
      clinical manifestations of patients with COVID-19 are wide, asymptomatic infection, mild
      upper respiratory tract illness, and approximately 5% of critically ill patients with
      COVID-19 have presented rapidly progressive respiratory failure, development of acute
      respiratory distress syndrome (ARDS), and intensive care unit (ICU) admission. On March 24,
      2020, the Secretary of Health of Mexico, formally declared the beginning of phase 2. It has
      been estimated that many confirmed cases of COVID-19 would occur, thus would result in a
      significant increase of hospital and ICU admissions.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">May 30, 2020</completion_date>
  <primary_completion_date type="Actual">April 30, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Hospital mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Mortality 30 days following hospital admission</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of stay in the intensive care unit</measure>
    <time_frame>Through study completion, an average of 30 days</time_frame>
    <description>The number of calendar days from the day of admission (counted as 1 day) to day of intensive care unit discharge</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Coronavirus Infections</condition>
  <condition>COVID-19</condition>
  <condition>Viral Pneumonia Human Coronavirus</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Critically ill patients aged over 18 years with a positive for SARS-CoV-2 result required
        admission to an intensive care unit or critical care in other areas of the hospital
        (critical care surge capacity).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed case: Critically ill patient who meets the operational definition of a
             suspected case and who has a confirmed diagnosis by the National Network of Public
             Health Laboratories recognized by the Institute of Epidemiological Diagnosis and
             Reference (Indre) (Mexico).

        Exclusion Criteria:

          -  If a negative for SARS-CoV-2 result is obtained from a critically ill patient with a
             high index of suspicion for COVID-19 virus infection.

          -  Patients who had participated in another observational study in the last 30 days prior
             to inclusion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Silvio A. Ñamendys-Silva, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guillermo Dominguez-Cherit, MD</last_name>
    <role>Study Director</role>
    <affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eduardo Rivero-Sigarroa, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</name>
      <address>
        <city>Mexico City</city>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>All centres from Mexico willing to contribute are Welcome.</name>
      <address>
        <city>Mexico</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <link>
    <url>https://criticalcaremexico.com.mx/en-gb</url>
    <description>Links to websites related to the study</description>
  </link>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 2, 2020</study_first_submitted>
  <study_first_submitted_qc>April 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 7, 2020</study_first_posted>
  <last_update_submitted>May 31, 2020</last_update_submitted>
  <last_update_submitted_qc>May 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</investigator_affiliation>
    <investigator_full_name>Silvio A. Ñamendys-Silva</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Intensive care unit</keyword>
  <keyword>Critical care</keyword>
  <keyword>Outcomes</keyword>
  <keyword>Epidemiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Pneumonia, Viral</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>All IPD that underlie could results in a publication.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

